Literature DB >> 19110486

Stem cell therapy for Alport syndrome: the hope beyond the hype.

Oliver Gross1, Dorin-Bogdan Borza, Hans-Joachim Anders, Christoph Licht, Manfred Weber, Stephan Segerer, Roser Torra, Marie-Claire Gubler, Laurence Heidet, Scott Harvey, Dominic Cosgrove, George Lees, Clifford Kashtan, Martin Gregory, Judy Savige, Jie Ding, Paul Thorner, Dale R Abrahamson, Corinne Antignac, Karl Tryggvason, Billy Hudson, Jeffrey H Miner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19110486      PMCID： PMC3888105          DOI： 10.1093/ndt/gfn722

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  13 in total

Review 1.  Alport's syndrome, Goodpasture's syndrome, and type IV collagen.

Authors:  Billy G Hudson; Karl Tryggvason; Munirathinam Sundaramoorthy; Eric G Neilson
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

2.  Stem cell-based therapy for glomerular diseases: an evolving concept.

Authors:  Valerie S LeBleu; Raghu Kalluri
Journal:  J Am Soc Nephrol       Date:  2008-08-13       Impact factor: 10.121

3.  Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome.

Authors:  Evangelia I Prodromidi; Richard Poulsom; Rosemary Jeffery; Candice A Roufosse; Patrick J Pollard; Charles D Pusey; H Terence Cook
Journal:  Stem Cells       Date:  2006-07-27       Impact factor: 6.277

4.  Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease.

Authors:  Hikaru Sugimoto; Thomas M Mundel; Malin Sund; Liang Xie; Dominic Cosgrove; Raghu Kalluri
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-28       Impact factor: 11.205

5.  Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice.

Authors:  Jeong Suk Kang; Xu-Ping Wang; Jeffrey H Miner; Roy Morello; Yoshikazu Sado; Dale R Abrahamson; Dorin-Bogdan Borza
Journal:  J Am Soc Nephrol       Date:  2006-06-12       Impact factor: 10.121

6.  Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome.

Authors:  Kaya L Andrews; Jacqueline L Mudd; Cong Li; Jeffrey H Miner
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

7.  Role of distinct type IV collagen networks in glomerular development and function.

Authors:  S J Harvey; K Zheng; Y Sado; I Naito; Y Ninomiya; R M Jacobs; B G Hudson; P S Thorner
Journal:  Kidney Int       Date:  1998-12       Impact factor: 10.612

8.  Irradiation prolongs survival of Alport mice.

Authors:  Kan Katayama; Mitsuo Kawano; Ichiro Naito; Hitoshi Ishikawa; Yoshikazu Sado; Nagisa Asakawa; Tomohiro Murata; Kazuki Oosugi; Michiyo Kiyohara; Eiji Ishikawa; Masaaki Ito; Shinsuke Nomura
Journal:  J Am Soc Nephrol       Date:  2008-05-14       Impact factor: 10.121

9.  Mouse model of X-linked Alport syndrome.

Authors:  Michelle N Rheault; Stefan M Kren; Beth K Thielen; Hector A Mesa; John T Crosson; William Thomas; Yoshikazu Sado; Clifford E Kashtan; Yoav Segal
Journal:  J Am Soc Nephrol       Date:  2004-06       Impact factor: 10.121

10.  Determinants of vascular permeability in the kidney glomerulus.

Authors:  Yuki Hamano; James A Grunkemeyer; Akulapalli Sudhakar; Michael Zeisberg; Dominic Cosgrove; Roy Morello; Brendan Lee; Hikaru Sugimoto; Raghu Kalluri
Journal:  J Biol Chem       Date:  2002-05-30       Impact factor: 5.157
View more
  15 in total

1.  Injection of amniotic fluid stem cells delays progression of renal fibrosis.

Authors:  Sargis Sedrakyan; Stefano Da Sacco; Anna Milanesi; Liron Shiri; Astgik Petrosyan; Radka Varimezova; David Warburton; Kevin V Lemley; Roger E De Filippo; Laura Perin
Journal:  J Am Soc Nephrol       Date:  2012-02-02       Impact factor: 10.121

Review 2.  Glomerular diseases: genetic causes and future therapeutics.

Authors:  Chih-Kang Chiang; Reiko Inagi
Journal:  Nat Rev Nephrol       Date:  2010-07-20       Impact factor: 28.314

3.  The regenerative potential of parietal epithelial cells in adult mice.

Authors:  Katja Berger; Kevin Schulte; Peter Boor; Christoph Kuppe; Toin H van Kuppevelt; Jürgen Floege; Bart Smeets; Marcus J Moeller
Journal:  J Am Soc Nephrol       Date:  2014-01-09       Impact factor: 10.121

4.  From Patient to Dish and Back Again: Are We There Yet?

Authors:  Uta Kunter; Marcus J Moeller
Journal:  J Am Soc Nephrol       Date:  2015-01-07       Impact factor: 10.121

Review 5.  Alport syndrome--insights from basic and clinical research.

Authors:  Jenny Kruegel; Diana Rubel; Oliver Gross
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

6.  Outcomes of male patients with Alport syndrome undergoing renal replacement therapy.

Authors:  Johanna Temme; Anneke Kramer; Kitty J Jager; Katharina Lange; Frederick Peters; Gerhard-Anton Müller; Reinhard Kramar; James G Heaf; Patrik Finne; Runolfur Palsson; Anna V Reisæter; Andries J Hoitsma; Wendy Metcalfe; Maurizio Postorino; Oscar Zurriaga; Julio P Santos; Pietro Ravani; Faical Jarraya; Enrico Verrina; Friedo W Dekker; Oliver Gross
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-20       Impact factor: 8.237

7.  Stem cell therapies benefit Alport syndrome.

Authors:  Valerie LeBleu; Hikaru Sugimoto; Thomas M Mundel; Behzad Gerami-Naini; Elizabeth Finan; Caroline A Miller; Vincent H Gattone; Lingge Lu; Charles F Shield; Judah Folkman; Raghu Kalluri
Journal:  J Am Soc Nephrol       Date:  2009-10-15       Impact factor: 10.121

8.  Feasibility of repairing glomerular basement membrane defects in Alport syndrome.

Authors:  Xiaobo Lin; Jung Hee Suh; Gloriosa Go; Jeffrey H Miner
Journal:  J Am Soc Nephrol       Date:  2013-11-21       Impact factor: 10.121

9.  Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative.

Authors:  Clifford E Kashtan; Jie Ding; Martin Gregory; Oliver Gross; Laurence Heidet; Bertrand Knebelmann; Michelle Rheault; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2012-03-30       Impact factor: 3.714

10.  Four danger response programs determine glomerular and tubulointerstitial kidney pathology: clotting, inflammation, epithelial and mesenchymal healing.

Authors:  Hans-Joachim Anders
Journal:  Organogenesis       Date:  2012-04-01       Impact factor: 2.500
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.